Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Infectious diseases physicians call for financial incentives for industry

In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.

25 Oct 2004

Insects implicated in the evolution of new human infectious diseases

Insects and other invertebrates are the arena for the evolution of new infectious diseases in humans, new research shows.

25 Oct 2004

New method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia

Research at Michigan State University found that a new test that provides a new, quicker method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia in newborns is effective more than 90 percent of the time.

22 Oct 2004

Bactericidal (bacteria-killing) versus bacteriostatic (bacteria-inhibiting) drugs for treating infections

When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.

21 Oct 2004

Sinusitis and bronchitis account for more than 30 million missed workdays each year

Sinusitis and bronchitis take a significant toll on a person's ability to participate in everyday life and have a sizable economic impact, accounting for more than 30 million missed workdays each year

21 Oct 2004

Scientists have devised a novel way to repair one of the genetic mutations that causes ataxia-telangiectasia

UCLA scientists have devised a novel way to repair one of the genetic mutations that causes ataxia-telangiectasia, (A-T), a life-shortening disorder that devastates the neurological and immune systems of one in 40,000 young children.

19 Oct 2004

Patients with chronic rhinosinusitis do not necessarily develop resistance to antibiotics

Patients with chronic rhinosinusitis (CRS, inflammation of the nasal passages and sinuses) do not necessarily develop resistance to antibiotics although they may be treated for long periods of time with these drugs

18 Oct 2004

Antibiotics are still being overused for treating common colds in New Zealand

A medical researcher at The University of Auckland says antibiotics are still being overused for treating common colds in New Zealand, despite researching showing their ineffectiveness.

18 Oct 2004

Warning signs and the latest treatment options for rosacea

For most people, a flushed face is a typical reaction to emotions ranging from excitement to embarrassment and sometimes even anger.

13 Oct 2004

Discovery of compound that renders the MRSA superbug vulnerable to antibiotics

MRSA- methicillin-resistant Staphylococcus aureus- is defined by its ability to resist the antibiotic methicillin. Like penicillin, methicillin works by blocking bacterial enzymes called PBPs, which normally strengthen cell walls by forming cross links.

13 Oct 2004

New research suggests that cancer cells can be reformed

New research by Dean Felsher, MD, PhD, assistant professor of medicine (oncology) and of pathology at the Stanford University School of Medicine, suggests that cancer cells can be reformed.

12 Oct 2004

Combination of computer science and biology could aid cancer research

The technique helps to show how cells modify their own genetic makeup and may allow cancer treatments to be tailored more precisely to a patient's disease.

11 Oct 2004

Results do not suggest widespread anthrax antibiotic abuse in the aftermath of the 2001 terrorist attacks

Prescriptions for antibiotics that could be taken in advance to prevent against anthrax were uncommon among concerned patients after September 11, 2001 and the 2001 U.S. anthrax attacks, according to an article in the October 11 issue of The Archives of Internal Medicine.

11 Oct 2004

Discovery could lead to the creation of naturally decaffeinated coffee plants

Chemists at Emory University have made an important advance in harnessing the ability of bacteria to make new molecules, and their discovery could eventually lead to the creation of naturally decaffeinated coffee plants.

10 Oct 2004

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

United States Department of Health and Human Services has announced four new contracts totaling more than $232 million to fund development of new vaccines against three potential agents of bioterrorism: smallpox, plague and tularemia. The National Institute of Allergy and Infectious Diseases (NIAID), will administer the contracts.

8 Oct 2004

Flu vaccine shortage highlights need to accelerate the approval of affordable generic biopharmaceuticals and vaccines

Following the announcement that the nation is facing a flu vaccine shortage this year, the Generic Pharmaceutical Association (GPhA) renewed its call for the Food and Drug Administration (FDA) and Congress to move forward to accelerate the approval of affordable generic biopharmaceuticals and vaccines.

8 Oct 2004

Antibiotic News and Research

Further Reading

Infectious diseases physicians call for financial incentives for industry

Insects implicated in the evolution of new human infectious diseases

New method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia

Bactericidal (bacteria-killing) versus bacteriostatic (bacteria-inhibiting) drugs for treating infections

Sinusitis and bronchitis account for more than 30 million missed workdays each year

Scientists have devised a novel way to repair one of the genetic mutations that causes ataxia-telangiectasia

Patients with chronic rhinosinusitis do not necessarily develop resistance to antibiotics

Antibiotics are still being overused for treating common colds in New Zealand

Warning signs and the latest treatment options for rosacea

Discovery of compound that renders the MRSA superbug vulnerable to antibiotics

New research suggests that cancer cells can be reformed

Combination of computer science and biology could aid cancer research

Results do not suggest widespread anthrax antibiotic abuse in the aftermath of the 2001 terrorist attacks

Discovery could lead to the creation of naturally decaffeinated coffee plants

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

Flu vaccine shortage highlights need to accelerate the approval of affordable generic biopharmaceuticals and vaccines

Repeated re-testing of women with a history of chlamydia is a cost-effective strategy for preserving reproductive health

New targets for combating infections in medical implants

Health Protection Agency investigates national outbreak of salmonella

RiboNovix secures license to novel anti-infective discovery technology from Wayne State University

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News